Keyphrases
5xFAD
52%
Active Compounds
27%
Alzheimer's Disease
49%
Alzheimer's Disease Model
74%
Alzheimer's Disease Treatment
18%
Amyloid beta
17%
Atrophy
17%
Axon
30%
Axonal Degeneration
55%
Axonal Growth
19%
Axonal Guidance
17%
Axonal Regeneration
15%
B-type
17%
Brain Penetration
17%
Brain Targeting
17%
Cerebral Cortex
19%
Cistanche Tubulosa
17%
Cognitive Function
36%
Combined Treatment
17%
Cortical Neurons
17%
Creatine kinase-MB (CK-MB)
17%
Dendrite
18%
Dendritic Atrophy
17%
Diosgenin
68%
Disease Model Mice
47%
Drynaria Fortunei
17%
Eleutherococcus Senticosus
34%
Enhancement Effect
17%
Galectin-1 (Gal-1)
17%
Healthy Adults
34%
Heat Shock Protein 70 (HSP70)
34%
Heptapeptide
17%
Locomotive Syndrome
17%
Memory Deficits
24%
Memory Enhancement
34%
Memory Function
52%
Memory Impairment
29%
Natural Medicine
17%
Novel Criterion
17%
Object Recognition Memory
31%
Oral Administration
41%
Placebo-controlled
51%
Randomized Double-blind Crossover Study
17%
Randomized Double-blind Study
34%
Secernin-1
17%
Target Molecule
17%
Trigonelline
20%
Tubulin
14%
VER-155008
17%
Water Extract
24%
Neuroscience
Adverse Effect
9%
Alzheimer's Disease
100%
Amnesia
23%
Amyloid Protein
27%
Axon
25%
Axonal Degeneration
55%
Blood Plasma
7%
Cerebral Cortex
11%
Cognitive Function
36%
Creatine Kinase
17%
Crossover Study
17%
Dendrite
11%
Diosgenin
59%
Eleutherococcus senticosus
17%
Galectin 1
8%
Glycogen Phosphorylase
8%
Heptapeptide
17%
Hippocampus
8%
In Vitro
5%
In Vivo
5%
Memory
43%
Memory Disorder
6%
Nerve Fiber Degeneration
55%
Neurite Outgrowth
5%
Osteonectin
8%
Placebo
34%
Recognition Memory
11%
Skeletal Muscle
7%
Skeletal Muscle Atrophy
5%
Spinal Cord Injury
8%
Trigonelline
17%
Tubulin
17%